TriNetX Publishes European Multiple Myeloma Real-World Evidence TherapyMonitor Report
TherapyMonitor Reports Offer Regulatory-Grade Insights Built Upon European Longitudinal and Representative Patient-Level Real-World Data CAMBRIDGE, Mass., April 12, 2023 /PRNewswire/ — TriNetX, through its wholly owned subsidiary TriNetX Oncology GmbH, announces the...